{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:31:16Z","timestamp":1764646276059,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00403-020-02117-7","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T08:03:51Z","timestamp":1597219431000},"page":"453-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunohistochemical study of perforin and apoptosis stimulation fragment ligand (FasL)in active vitiligo"],"prefix":"10.1007","volume":"313","author":[{"given":"Akmal Saad","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May Malek","family":"Kohil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safinaz Salah Eldin","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4326-4319","authenticated-orcid":false,"given":"Sara Bahaa","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"2117_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jaad.2016.12.040","volume":"76","author":"L Benzekri","year":"2017","unstructured":"Benzekri L, Gauthier Y (2017) Clinical markers of vitiligo activity. J Am Acad Dermatol 76:856\u2013862","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2117_CR2","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/ijms19051509","volume":"19","author":"A Bishnoi","year":"2018","unstructured":"Bishnoi A, Parsad D (2018) Clinical and molecular aspects of vitiligo treatments. Int J Mol Sci 19(5):1509","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2117_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","volume":"46","author":"S Cheuk","year":"2017","unstructured":"Cheuk S, Schlums H, Gallais S\u00e9r\u00e9zal I, Martini E, Chiang SC, Marquardt N, Gibbs A, Detlofsson E, Introini A, Forkel M, H\u00f6\u00f6g C, Tjernlund A, Micha\u00eblsson J, Folkersen L, Mj\u00f6sberg J, Blomqvist L, Ehrstr\u00f6m M, St\u00e5hle M, Bryceson YT, Eidsmo L (2017) CD49a\u00a0expression\u00a0defines tissue-resident CD8+\u00a0T cells poised for cytotoxic function in human skin. Immunity 46(2):287\u2013300","journal-title":"Immunity"},{"issue":"6","key":"2117_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/archderm.140.6.677","volume":"140","author":"I Hamzavi","year":"2004","unstructured":"Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H (2004) Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol 140(6):677\u2013683","journal-title":"Arch Dermatol"},{"issue":"5","key":"2117_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2165\/00128071-200203050-00001","volume":"3","author":"CL Huang","year":"2002","unstructured":"Huang CL, Nordlund JJ, Boissy R (2002) Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 3(5):301\u2013308","journal-title":"Am J Clin Dermatol"},{"key":"2117_CR6","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.4049\/jimmunol.177.5.3055","volume":"177","author":"T Lambe","year":"2006","unstructured":"Lambe T, Leung JC, Bouriez-Jones T, Silver K, Makinen K, Crockford TL, Ferry H, Forrester JV, Cornall RJ (2006) CD4 T lymphocytes-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions. J Immunol 177:3055\u20133062","journal-title":"J Immunol"},{"key":"2117_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1046\/j.1523-1747.2001.01363.x","volume":"116","author":"KS Lang","year":"2001","unstructured":"Lang KS, Caroli CC, Muhm A, Wernet D, Moris A, Schittek B, Knauss-Scherwitz E, Stevanovic S, Rammensee HG, Garbe C (2001) HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA\/MART1. J Invest Dermatol 116:891\u2013897","journal-title":"J Invest Dermatol"},{"key":"2117_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1046\/j.0022-202x.2001.01605.x","volume":"117","author":"FA Le Gal","year":"2001","unstructured":"Le Gal FA, Avril MF, Bosq J, Lefebvre P, Deschemin JC, Andrieu M, Knauss-Scherwitz E, Stevanovic S, Rammensee HG, Garbe C (2001) Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo. J Invest Dermatol 117:1464\u20131470","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2117_CR9","first-page":"1219","volume":"148","author":"IC Le Poole","year":"1996","unstructured":"Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK (1996) Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 148(4):1219\u20131228","journal-title":"Am J Pathol"},{"key":"2117_CR10","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/jid.2008.161","volume":"128","author":"M Li","year":"2008","unstructured":"Li M, Sun D, Li C, Zhang Z, Gao L, Li K, Li H, Gao T (2008) Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis. J Invest Dermatol 128:2820\u20132824","journal-title":"J Invest Dermatol"},{"key":"2117_CR11","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1182\/blood-2012-07-446146","volume":"121","author":"JA Lopez","year":"2013","unstructured":"Lopez JA, Susanto O, Jenkins MR, Lukoyanova N, Sutton VR, Law RH, Johnston A, Bird CH, Bird PI, Whisstock JC, Trapani JA, Saibil HR, Voskoboinik I (2013) Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack. Blood 121:2659\u20132668","journal-title":"Blood"},{"issue":"9","key":"2117_CR12","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3324\/haematol.2014.114967","volume":"100","author":"S Nabhani","year":"2015","unstructured":"Nabhani S, Ginzel S, Miskin H, Revel-Vilk S, Harlev D, Fleckenstein B, H\u00f6nscheid A, Oommen PT, Kuhlen M, Thiele R, Laws HJ, Borkhardt A, Stepensky P, Fischer U (2015) Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease. Haematologica 100(9):1189\u20131198","journal-title":"Haematologica"},{"issue":"4","key":"2117_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/archderm.135.4.407","volume":"135","author":"MD Njoo","year":"1999","unstructured":"Njoo MD, Das PK, Bos JD, Westerhof W (1999) Association of the K\u00f6bner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 135(4):407\u2013413","journal-title":"Arch Dermatol"},{"key":"2117_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM (2003) Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 16:90\u2013100","journal-title":"Pigment Cell Res"},{"key":"2117_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/1874372200802010105","volume":"2","author":"FM Pretti Aslanian","year":"2008","unstructured":"Pretti Aslanian FM, No\u00e9 RA, Antelo DP, Farias RE, Das PK, Galadari I, Cuzzi T, Filgueira AL (2008) Immunohistochemical findings in active vitiligo including depigmenting lesions and non-lesional skin. Open Dermatol J 2:105\u2013110","journal-title":"Open Dermatol J"},{"issue":"2","key":"2117_CR16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1600-0749.2007.00366.x","volume":"20","author":"FM Pretti Aslanian","year":"2007","unstructured":"Pretti Aslanian FM, Noe RA, Cuzzi T, Filgueira AL (2007) Abnormal histological findings in active vitiligo include the normal-appearing skin. Pigment Cell Res 20(2):144\u2013145","journal-title":"Pigment Cell Res"},{"key":"2117_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.11648\/j.cmr.20130205.13","volume":"2","author":"FY Saleh","year":"2013","unstructured":"Saleh FY, Awad SS, Sadek IM (2013) Lymphocytic expression of Fas and FasL apoptotic markers in vitiligo. Clin Med Res 2:105\u2013109","journal-title":"Clin Med Res"},{"issue":"1","key":"2117_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/toxins6010194","volume":"6","author":"SC Su","year":"2014","unstructured":"Su SC, Chung WH (2014) Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions. Toxins (Basel) 6(1):194\u2013210","journal-title":"Toxins (Basel)"},{"key":"2117_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2133.1978.tb01988.x","volume":"99","author":"RD Sweet","year":"1978","unstructured":"Sweet RD (1978) Vitiligo as a Koebner phenomenon. Br J Dermatol 99:223\u2013224","journal-title":"Br J Dermatol"},{"key":"2117_CR20","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/jid.2009.32","volume":"129","author":"JG van den Boorn","year":"2009","unstructured":"van den Boorn JG, Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM (2009) Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 129:2220\u20132232","journal-title":"J Invest Dermatol"},{"issue":"8","key":"2117_CR21","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/labinvest.3780138","volume":"80","author":"R van den Wijngaard","year":"2000","unstructured":"van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P (2000) Local\u00a0immune\u00a0response\u00a0in\u00a0skin\u00a0of generalized vitiligo patients Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 80(8):1299\u20131309","journal-title":"Lab Invest"},{"issue":"2","key":"2117_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1523-1747.2000.00037.x","volume":"115","author":"P Wehrli","year":"2000","unstructured":"Wehrli P, Viard I, Bullani R, Tschopp J, French LE (2000) Death receptors in cutaneous biology and disease. J Invest Dermatol 115(2):141\u2013148","journal-title":"J Invest Dermatol"},{"issue":"1","key":"2117_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3892\/mmr.2012.1117","volume":"7","author":"J Wu","year":"2013","unstructured":"Wu J, Zhou M, Wan Y, Xu A (2013) CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis. Mol Med Rep 7(1):237\u2013241","journal-title":"Mol Med Rep"},{"issue":"1","key":"2117_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jdermsci.2017.03.008","volume":"87","author":"Y Yang","year":"2017","unstructured":"Yang Y, Li S, Zhu G, Zhang Q, Wang G, Gao T, Li C, Wang L, Jian Z (2017) A similar local immune and oxidative stress phenotype in\u00a0vitiligo\u00a0and halo nevus. J Dermatol Sci 87(1):50\u201359","journal-title":"J Dermatol Sci"},{"issue":"1","key":"2117_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/cei.12146","volume":"174","author":"S You","year":"2013","unstructured":"You S, Cho Y, Byun JS, Shin EC (2013) Melanocyte-specific CD8+\u00a0T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo. Clin Exp Immunol 174(1):38\u201344","journal-title":"Clin Exp Immunol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02117-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:32:35Z","timestamp":1628724755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02117-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2117"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02117-7","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"type":"print","value":"0340-3696"},{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"13 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}